The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.
Https://www.londonstockexchange.com/news-article/PYC/board-changes/16297513
Interseting turn if events.
Many have called for Jim Millen to be removed.
My first question is, will Peter be buying a substantial amount of stock to back these " I can see many exciting opportunities ahead for us. I look forward to speaking to shareholders next week and over the course of 2024."
Project Optimus seeks to improve the dose optimisation and dose selection paradigm in #oncology #drugdevelopment. The focus is on conducting these studies as early as possible in the #drugdevelopment process. 👇 https://fda.gov/about-fda/oncology-center-excellence/project-optimus #pharma
My critism on this post is they do not put hash tag # in front of Project Optimus and there is no #PYC
I thought that thursday we ended flat, and Friday we ended in positive territory, so where was the 2 consequective blue days?
KJH i read your reply to the Project Optimus post, and i agree 100% with everything you stated.
Laura, i did say ot was a old wives tale regarding the 1 code? We've had numerous now 1 trades, and no RNS so yep, its rubbish.
a trade of 100 or 200 is also a old wives tale regarding MM's secret codes, probably bunkum to.
PYC did tweet or X or whatever you cal it now and mentioned Project Optimus
https://www.imperial.ac.uk/advanced-therapeutics-centre/
https://advancedtherapeutics.org.uk/
https://www.mewburn.com/spotlight-on-advanced-therapeutics
https://mkainsights.com/insights/biotech-pharma-healthcare/what-are-advanced-therapies/
Its indeed unbelieveable that people have been arguing if the 250k was a buy or sell. I thought it was a sell myself as the price went down shortly afterwards.
Its also unbelieveable that this site has the price down over 14% when it should be uder 3%
Freudian slip on the headline Laura :-) AI could be a gold mine.
I like the final sentence “These themes include precision medicine, genetic medicine, cell therapy, immunotherapy, synthetic biology, and artificial intelligence"
However, for any of this GMS $ to get to PYC or to any of the companies that use their service remains a very long shot.
The tweet that they put out and said "Here's to a year full of growth! 🥂" I just hope they do not mean growth in finacial losses, or growth in shareholder's losses.
Some not so good news over at VAL with placing etc. Lots of chatter about 201 and nothing happening with it. No matter what people think its worth to PYC be it £1 or £6m it needs to be forgotten about till something concrete actually happens.
Could be a very thin silver lining to PYC with the VALs raise, they need the £ for 3-4 new projects etc, maybe PYC could benefit from that possible work?
Https://mailchi.mp/7d27f56e2efd/physiomics-year-in-review-2023?e=db21dcf230
Hopefully it can be read from this link?
PYC sent out a year review via email earlier.
Just the rehashed news we already knew about.
starts of with this sentence " From us to you - our top moments of 2023!
2023 has been an eventful and exciting year for Physiomics, from welcoming new members to the team and moving to our new offices, to bringing new clients and collaborators onboard to work with us – it’s been a great year! Read on as we reflect on some of our highlights of 2023! "
Might have been exciting for them, but for shareholders, it has been rubbish, with the share price being sent into the abyss.
Below is the conclusion from the AACR abstract in Oct 2023.
https://ankyratx.com/wp-content/uploads/2023/10/PYC_EORTC_Poster_2023_FINAL.pdf
Then as pointed out yesterday. https://aacrjournals.org/mct/article/22/12_Supplement/A141/730575/Abstract-A141-Preclinical-pharmacokinetic-PK-and a big difference in the conclusions, in the space of a few months?
42 posts today, way way more than the amount of trades. Some may think there had been a explosion of news, ah no, just back and forth inteligent debate, i wish.
A whole raft of posts removed from 1345 onwards, possibly some removed during the day. I wish that the 2 sides would cancel each other out, and leave the middle ground for the tiny minority. However, the battle for supremacy rages on.
PYC mentioned #ProjectOptimimus yesterday for the 1st time in ages.
People should keep a eye on Cellcentric and what their lead molecule is doing "Inobrodip" PYC did work for them on this, and should in my view be singing loud and proud about it.
Its great news, for men that may suffer PC in the near future. Trial starts in spring 24 and recruiting in late 24. As you say, PYC not involved with the sceening process. PC has already a lot of drugs on the market or heading towards it. You could hypothesise that in the future other drugs will come to the market, and they will need evaluating, and in conjunction with Project Optimus. If PYC will be involved, who knows?